DarioHealth (DRIO) Cash from Financing Activities (2012 - 2025)

DarioHealth's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at -$19000.0 for Q4 2025.

• Quarterly Cash from Financing Activities fell 100.1% year-over-year to -$19000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.3 million (down 36.9% YoY) and the FY2025 annual result came in at $24.3 million, down 36.9% from the prior year.
• Cash from Financing Activities was -$19000.0 for Q4 2025 at DarioHealth, down from $17.4 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $65.7 million in Q1 2021 and bottomed at -$1.4 million in Q1 2023.
• A 5-year average of $14.9 million and a median of $12.1 million in 2025 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 42903.64% — and 2023, when it sank 103.65%.
• DarioHealth's Cash from Financing Activities stood at $55000.0 in 2021, then soared by 381.82% to $265000.0 in 2022, then dropped by 23.02% to $204000.0 in 2023, then surged by 8882.84% to $18.3 million in 2024, then plunged by 100.1% to -$19000.0 in 2025.
• Business Quant data shows DRIO's Cash from Financing Activities at -$19000.0 in Q4 2025, $17.4 million in Q3 2025, and $124000.0 in Q2 2025.